MicroRNA-497 regulates the proliferation of clear cell renal cell carcinoma via interleukin-6 receptor

References

• Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–E386.
   PubMed Web of Science ®Google Scholar
• Park BK. Renal angiomyolipoma based on new classification: how to differentiate it from renal cell carcinoma. Am J Roentgenol. 2019;212:582–588.
   PubMed Web of Science ®Google Scholar
• Jonasch E, Gao J, Rathmell WK. Renal cell carcinoma. BMJ (Clin Res Ed). 2014;349:g4797.
   PubMed Web of Science ®Google Scholar
• Chen Y, Liu J, Lv P, et al. IL-6 is involved in malignancy and doxorubicin sensitivity of renal carcinoma cells. Cell Adh Migr. 2018; 12:28–36.
   PubMed Web of Science ®Google Scholar
• Kaminska K, Czarnecka AM, Escudier B, et al. Interleukin-6 as an emerging regulator of renal cell cancer. Urol Oncol. 2015; 33:476–485.
   PubMed Web of Science ®Google Scholar
• Wolf J, Waetzig GH, Chalaris A, et al. Different soluble forms of the interleukin-6 family signal transducer gp130 fine-tune the blockade of interleukin-6 trans-signaling. J Biol Chem. 2016;291:16186–16196.
   PubMed Web of Science ®Google Scholar
• Graziano A, Lo Monte G, Piva I, et al. Diagnostic findings in adenomyosis: a pictorial review on the major concerns. Eur Rev Med Pharmacol Sci. 2015; 19:1146–1154.
   PubMed Web of Science ®Google Scholar
• Jia W, Wu Y, Zhang Q, et al. Expression profile of circulating microRNAs as a promising fingerprint for cervical cancer diagnosis and monitoring. Mol Clin Oncol. 2015; 3:851–858.
   PubMed Web of Science ®Google Scholar
• Wang C, Cai L, Liu J, et al. MicroRNA-30a-5p inhibits the growth of renal cell carcinoma by modulating GRP78 expression. Cell Physiol Biochem. 2017;43:2405–2419.
   PubMedGoogle Scholar
• Marchionni L, Hayashi M, Guida E, et al. MicroRNA expression profiling of Xp11 renal cell carcinoma. Hum Pathol. 2017; 67:18–29.
   PubMed Web of Science ®Google Scholar
• Li WA, Efendizade A, Ding Y. The role of microRNA in neuronal inflammation and survival in the post ischemic brain: a review. Neurol Res. 2017;1–9.
   PubMedGoogle Scholar
• Pengcheng S, Ziqi W, Luyao Y, et al. MicroRNA-497 suppresses renal cell carcinoma by targeting VEGFR-2 in ACHN cells. Biosci Rep. 2017; 37.
   PubMed Web of Science ®Google Scholar
• Zhao X, Zhao Z, Xu W, et al. Down-regulation of miR-497 is associated with poor prognosis in renal cancer. Int J Clin Exp Pathol. 2015;8:758–764.
   PubMedGoogle Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001; 25:402–408.
   PubMed Web of Science ®Google Scholar
• Daniel CR, Cross AJ, Graubard BI, et al. Large prospective investigation of meat intake, related mutagens, and risk of renal cell carcinoma. Am J Clin Nutr. 2012; 95:155–162.
   PubMed Web of Science ®Google Scholar
• Pischon T, Lahmann PH, Boeing H, et al. Body size and risk of renal cell carcinoma in the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer. 2006; 118:728–738.
   PubMed Web of Science ®Google Scholar
• Van Poppel H, Da Pozzo L, Albrecht W, et al. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol. 2011; 59:543–552.
   PubMed Web of Science ®Google Scholar
• Hoffmann NE, Gillett MD, Cheville JC, et al. Differences in organ system of distant metastasis by renal cell carcinoma subtype. J Urol. 2008; 179:474–477.
   PubMed Web of Science ®Google Scholar
• Medical Research Council Renal Cancer Collaborators. Interferon-alpha and survival in metastatic renal carcinoma: early results of a randomised controlled trial. Lancet. 1999; 353:14–17.
   PubMedGoogle Scholar
• Tone M, Powell MJ, Tone Y, et al. IL-10 gene expression is controlled by the transcription factors Sp1 and Sp3. J Immunol. 2000; 165:286–291.
   PubMed Web of Science ®Google Scholar
• Luo Q, Ma X, Wahl SM, et al. Activation and repression of interleukin-12 p40 transcription by erythroid Kruppel-like factor in macrophages. J Biol Chem. 2004; 279:18451–18456.
   PubMed Web of Science ®Google Scholar
• Baeuerle PA, Henkel T. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol. 1994;12:141–179.
   PubMed Web of Science ®Google Scholar
• Heo TH, Wahler J, Suh N. Potential therapeutic implications of IL-6/IL-6R/gp130-targeting agents in breast cancer. Oncotarget. 2016; 7:15460–15473.
   PubMedGoogle Scholar
• Yao X, Huang J, Zhong H, et al. Targeting interleukin-6 in inflammatory autoimmune diseases and cancers. Pharmacol Ther. 2014; 141:125–139.
   PubMed Web of Science ®Google Scholar
• Oguro T, Ishibashi K, Sugino T, et al. Humanised antihuman IL-6R antibody with interferon inhibits renal cell carcinoma cell growth in vitro and in vivo through suppressed SOCS3 expression. Eur J Cancer. 2013; 49:1715–1724.
   PubMed Web of Science ®Google Scholar
• Guo ST, Jiang CC, Wang GP, et al. MicroRNA-497 targets insulin-like growth factor 1 receptor and has a tumour suppressive role in human colorectal cancer. Oncogene. 2013; 32:1910–1920.
   PubMed Web of Science ®Google Scholar
• Wang W, Ren F, Wu Q, et al. MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth factor A through the PI3K/AKT and MAPK/ERK pathways in ovarian cancer. Oncol Rep. 2014; 32:2127–2133.
   PubMed Web of Science ®Google Scholar
• Han J, Huo M, Mu M, et al. miR-497 suppresses proliferation of human cervical carcinoma HeLa cells by targeting cyclin E1. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi = Chin J Cell Mol Immunol. 2014; 30:597–600.
   PubMedGoogle Scholar
• Li W, Jin X, Deng X, et al. The putative tumor suppressor microRNA-497 modulates gastric cancer cell proliferation and invasion by repressing eIF4E. Biochem Biophys Res Commun. 2014; 449:235–240.
   PubMed Web of Science ®Google Scholar
• Xie Y, Wei RR, Huang GL, et al. Checkpoint kinase 1 is negatively regulated by miR-497 in hepatocellular carcinoma. Med Oncol. 2014; 31:844.
   PubMed Web of Science ®Google Scholar